Evidence map›Paper›PMID 35944242›Full record

ArticleMedical anthropology2023

Reliving it All Over Again: Uncanny Temporalities of Injection Drug Use and Hepatitis C Diagnosis in Southwest Virginia, USA.

Joshua Burraway, Bailey Helbert, Julie Schexnayder, Terry Knick, Rebecca Dillingham, China Scherz

Open access · greenAbstract read
In one paragraph

Article in Medical anthropology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Joshua BurrawayDeloitte Digital, London, UK.
Bailey HelbertDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Julie SchexnayderDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Terry KnickDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Rebecca DillinghamDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
China ScherzDepartment of Anthropology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-5562-8538
University of Virginia · USDeloitte (United States) · US

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Deconstructing HIV Disparities: Multistate Study of Data, Outcomes and MediatorsK08AI136644 · NIAID · UNIVERSITY OF VIRGINIA · PI MCMANUS, KATHLEEN ANN · 2018 to 2022
$1.0M
NIAID NIH HHS K08 AI136644NIAID NIH HHS T32 AI007046
6 · The paper itself

Abstract

Clinicians typically view the intersection between hepatitis C and injection drug use in terms of simultaneity - with transmission occurring via shared needles - or sequentially - with some states requiring that people stop using drugs prior to treatment. Yet, for patients, the connection between substance use and HCV infection can follow a more complex temporal pathway. In this article, we explore the non-linear temporality of "reliving" as it shapes HCV illness experience, its complex intersection with injection drug use, and the barriers patients face as they reckon with existing healthcare system responses and treatment modalities.

Indexed as

Hepatitis CSubstance Abuse, IntravenousSubstance-Related DisordersAnthropology, MedicalHumansVirginiaDiagnosishepatitis Cnarrativerural injection drug usetemporalityUSA

Identifiers

PMID35944242
PMCPMC9822844
OpenAlexW4292458034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.